Highlights

  • The bribe was alleged to waive phase-three clinical trial of Insulin Aspart injection
  • The said injection is an underdevelopment product of Biocon Biologic

Latest news

Asus Pad T3201 Review: OLED Brilliance Meets Everyday Mid-Range Power

Asus Pad T3201 Review: OLED Brilliance Meets Everyday Mid-Range Power

Qualcomm Showcases Snapdragon 8 Elite Gen 6 Chips At IMC 2026, Teases New Flagships

Qualcomm Showcases Snapdragon 8 Elite Gen 6 Chips At IMC 2026, Teases New Flagships

Shokz Diwali Sale Brings Discounts On Open-Ear Headphones Across Amazon And Flipkart

Shokz Diwali Sale Brings Discounts On Open-Ear Headphones Across Amazon And Flipkart

iQOO 16 Confirmed For India With Snapdragon 8 Elite Extreme Gen 6 And OriginOS 7

iQOO 16 Confirmed For India With Snapdragon 8 Elite Extreme Gen 6 And OriginOS 7

ASUS Announces Festive Discounts Across Laptops, Gaming PCs And Tablets

ASUS Announces Festive Discounts Across Laptops, Gaming PCs And Tablets

Priyanka Gandhi lies on ground, Rahul detained as Delhi Police stop INDIA bloc MPs' Jantar Mantar march

Priyanka Gandhi lies on ground, Rahul detained as Delhi Police stop INDIA bloc MPs' Jantar Mantar march

Emotion, tears as Messi retires from Argentina national team

Emotion, tears as Messi retires from Argentina national team

Rajpal Yadav tells CJI Surya Kant his legal troubles inspired film title ‘Solah Sawan Jhel Ke’

Rajpal Yadav tells CJI Surya Kant his legal troubles inspired film title ‘Solah Sawan Jhel Ke’

No wrong doing! Kiran Mazumdar-Shaw lashes out, waiver was procedural

The CBI registered a case of criminal conspiracy and corruption against Reddy, posted at CDSCO headquarters, and Dinesh Dua, Director at Synergy Network India Private Limited, among others

No wrong doing! Kiran Mazumdar-Shaw lashes out, waiver was procedural

Hitting out strongly against media reports alleging bribery charges favouring Biocon's unit, Kiran Mazumdar-Shaw took to Twitter to not only deny the allegations but also to shut down trolls.

Shaw took an aggressive stance to safeguard the integrity of Biocon as she reminded netizens to read and understand before spreading fake news. The founder of Biocon denied all allegations of wrong doing reported in a PTI news copy that had alleged a 4 lakh bribe was given to a drug controller to waive off a critical insulin trial.

Also read/watch| Bribe allegations on Biocon's injection unit, Joint drugs controller arrested

Citing procedure Kiran Mazumdar Shaw explained that "The product is EU approved n has conducted full trials globally. All that has been sought is an India trial waiver OK? Pls understand facts before jumping to conclusions. CDSCO provides for trial waiver for EU n US approved products."

Biocon Biologics - the unit under question has also issued a statement denying all allegations and is cooperating with CBI as all material and filings are available online with minutes of meetings as well.

Frequently Asked Questions

Kiran Mazumdar-Shaw denied allegations of bribery favouring Biocon's unit and urged netizens to understand the facts before spreading fake news.

ADVERTISEMENT

Up Next

No wrong doing! Kiran Mazumdar-Shaw lashes out, waiver was procedural

No wrong doing! Kiran Mazumdar-Shaw lashes out, waiver was procedural

Sensex falls 429 points, Nifty slips 173 points after RBI rate hike

Sensex falls 429 points, Nifty slips 173 points after RBI rate hike

RBI raises repo rate by 25 bps to 5.50%, shifts policy towards tightening

RBI raises repo rate by 25 bps to 5.50%, shifts policy towards tightening

GST rates likely unchanged as 57th Council meeting focuses on reforms

GST rates likely unchanged as 57th Council meeting focuses on reforms

Sensex gains 685 points, Nifty rises 220 points to cross 22,700

Sensex gains 685 points, Nifty rises 220 points to cross 22,700

Sensex gains 473 points, Nifty rises 134 points as markets stage recovery

Sensex gains 473 points, Nifty rises 134 points as markets stage recovery

ADVERTISEMENT

editorji-whatsApp

More videos

India To Grow 7% In FY27, Next Growth Phase Hinges On Infra, Deeper Capital Markets: S&P Global

India To Grow 7% In FY27, Next Growth Phase Hinges On Infra, Deeper Capital Markets: S&P Global

Sensex Falls 49 Points, Nifty Slips 96 As Selling Pressure Returns

Sensex Falls 49 Points, Nifty Slips 96 As Selling Pressure Returns

Sensex falls 243 points, Nifty slips 64 points as foreign outflows and crude prices weigh

Sensex falls 243 points, Nifty slips 64 points as foreign outflows and crude prices weigh

India launches anti-dumping probes into 7 Chinese products, including key pharma ingredients

India launches anti-dumping probes into 7 Chinese products, including key pharma ingredients

Sensex crashes 1,124 points, Nifty falls 1.56% as crude surges above $107

Sensex crashes 1,124 points, Nifty falls 1.56% as crude surges above $107

Sensex Rises 315 Points, Nifty Gains 77 as Markets Recover After Sharp Sell-Off

Sensex Rises 315 Points, Nifty Gains 77 as Markets Recover After Sharp Sell-Off

Sensex Crashes 1,248 Points, Nifty Falls 1.64% Amid Global Cues

Sensex Crashes 1,248 Points, Nifty Falls 1.64% Amid Global Cues

Sensex, Nifty End Higher As Domestic Growth Signals, Softer Crude Support Sentiment

Sensex, Nifty End Higher As Domestic Growth Signals, Softer Crude Support Sentiment

UPI Payments In Uzbekistan: Indian Travellers To Get QR-Based Payment Option

UPI Payments In Uzbekistan: Indian Travellers To Get QR-Based Payment Option

India’s Q1 GDP Growth Hits 7.8%, Beats RBI Estimate

India’s Q1 GDP Growth Hits 7.8%, Beats RBI Estimate

Editorji Technologies Pvt. Ltd. © 2022 All Rights Reserved.